Back to search

Boston University

Optoacoustic neuromodulation mediated by fiber devices and blood

Abstract

dc:description.abstract

Neuromodulation has become an essential tool for probing and treating the nervous system, offering precise control of neural activity through electrical, magnetic, acoustic, optical, or chemical approaches. By enabling targeted and reversible manipulation, neuromodulation supports causal investigations of brain function and provides effective therapeutic strategies for conditions such as Parkinson’s disease, epilepsy, chronic pain, and treatment-resistant depression. Recent advances in minimally invasive and noninvasive techniques—including focused ultrasound, transcranial magnetic stimulation, and emerging photoacoustic (PA) stimulation—are further expanding access to deep-brain targets while reducing systemic side effects.Despite rapid progress, key obstacles limit the broader adoption of PA neuromodulation. Current PA emitters exhibit suboptimal optoacoustic conversion efficiency, requiring high optical fluence that elevates the risk of photothermal toxicity and constrains long-term use. In addition, the underlying biophysical mechanism of PA neuromodulation remains insufficiently understood. Extending PA neuromodulation into in vivo applications introduces further challenges related to device stability, biocompatibility, and compatibility with widely used brain-recording platforms, including calcium imaging, electrophysiology, and integrated multimodal systems. To address these limitations, this thesis presents a next-generation PA emitter architecture with a ten-fold improvement in conversion efficiency, enabling safer and more energy-efficient stimulation. This enhanced performance provides the foundation for mechanistic studies at the cellular scale. Furthermore, an optical imaging system was designed to capture direct optical evidence for understanding the PA modulation mechanism. Finally, a novel in vivo PA neuromodulation strategy was demonstrated that uses blood as an endogenous absorber, achieving excellent compatibility with existing brain-imaging technologies. Together, these advances establish a robust framework for non-genetic, high-precision PA neuromodulation both in vitro and in vivo.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Electrical & Computer Engineering
Grantor
Boston University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chen, Guo
Advisor dc:contributor.advisor
  • Yang, Chen
ORCID dc:identifier.orcid

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52140

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Chen, Guo. Optoacoustic neuromodulation mediated by fiber devices and blood. doctoral thesis, Boston University, 2026. https://hdl.handle.net/2144/52140